Effectiveness of Stearyl-CoA desaturase inhibitors in GBM

Project: Research project

Project Details

Description

To test the efficacy of of Yumanity’s Stearyl-CoA desaturase (SCD) inhibitors YTX-7739 and YTX-9184 in immunocompetent models of glioblastoma (GBM) and identify relevant immunotherapeutic combinations that may synergize with SCD inhibitors.
StatusFinished
Effective start/end date10/1/219/30/23

Funding

  • Proteostasis Therapeutics, Inc. (Agmt 12/16/2021 PO 19386)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.